REFERENCES
1. Landis ET, Davis SA, Taheri A, Feldman SR. Top dermatologic diagnoses by age. Dermatol Online J. 2014;20(4). doi:10.5070/d3204022368.
2. Peck GM, Roberson FA, Feldman SR. Why do patients in the united states seek care from dermatologists? Dermatol Ther. 2022;12(4):1065- 1072. doi:10.1007/s13555-022-00706-0.
3. Baldwin HE, Bhatia ND, Friedman A, Eng RM, Seite S. The role of cutaneous microbiota harmony in maintaining a functional skin barrier. J Drugs Dermatol. 2017;16(1):12-18.
4. NIH HMP Working Group, Peterson J, Garges S, et al. The NIH Human Microbiome Project. Genome Res. 2009;19(12):2317-2323. doi: 10.1101/gr.096651.109.
5. Cunliffe WJ, Gould DJ. Prevalence of facial AV in late adolescence and in adults. Br Med J. 1979;1(6171):1109-1110. doi:10.1136/bmj.1.6171.1109
6. Pappas, A., Dunn, K., Cula, G.O., et al. Barrier and microbiome changes in the facial skin of children as they approach puberty. Presented at: 26th European Academy of Dermatology and Venerology (EADV) Congress: P006513; September 17, 2017; Geneva Switzerland.
7. Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in AV. Arch Dermatol Res. 1995;287(2):214-218. doi:10.1007/BF01262335
8. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148-155. doi:10.1016/j.jaad.2017.08.037.
9. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499-514. doi:10.1016/j.jaad.2004.03.033
10. Draelos ZD. Cosmetics in acne and rosacea. Semin Cutan Med Surg. 2001;20(3):209-214. doi:10.1053/sder.2001.27556
11. Del Rosso JQ. The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the assessment of skin characteristics study. Cutis. 2009;84(2):72-76.
12. Subramanyan K. Role of mild cleansing in the management of patient skin. Dermatol Ther. 2004;17 (Suppl 1):26-34. doi:10.1111/j.1396- 0296.2004.04s1003.x
13. Draelos ZD, Green BA, Edison BL. An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. J Cosmet Dermatol. 2006;5(1):23-29. doi:10.1111/j.1473- 2165.2006.00219.x
14. Holmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol. 2013;69(6):1025-1032. doi:10.1016/j. jaad.2013.08.006
2. Peck GM, Roberson FA, Feldman SR. Why do patients in the united states seek care from dermatologists? Dermatol Ther. 2022;12(4):1065- 1072. doi:10.1007/s13555-022-00706-0.
3. Baldwin HE, Bhatia ND, Friedman A, Eng RM, Seite S. The role of cutaneous microbiota harmony in maintaining a functional skin barrier. J Drugs Dermatol. 2017;16(1):12-18.
4. NIH HMP Working Group, Peterson J, Garges S, et al. The NIH Human Microbiome Project. Genome Res. 2009;19(12):2317-2323. doi: 10.1101/gr.096651.109.
5. Cunliffe WJ, Gould DJ. Prevalence of facial AV in late adolescence and in adults. Br Med J. 1979;1(6171):1109-1110. doi:10.1136/bmj.1.6171.1109
6. Pappas, A., Dunn, K., Cula, G.O., et al. Barrier and microbiome changes in the facial skin of children as they approach puberty. Presented at: 26th European Academy of Dermatology and Venerology (EADV) Congress: P006513; September 17, 2017; Geneva Switzerland.
7. Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in AV. Arch Dermatol Res. 1995;287(2):214-218. doi:10.1007/BF01262335
8. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148-155. doi:10.1016/j.jaad.2017.08.037.
9. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499-514. doi:10.1016/j.jaad.2004.03.033
10. Draelos ZD. Cosmetics in acne and rosacea. Semin Cutan Med Surg. 2001;20(3):209-214. doi:10.1053/sder.2001.27556
11. Del Rosso JQ. The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the assessment of skin characteristics study. Cutis. 2009;84(2):72-76.
12. Subramanyan K. Role of mild cleansing in the management of patient skin. Dermatol Ther. 2004;17 (Suppl 1):26-34. doi:10.1111/j.1396- 0296.2004.04s1003.x
13. Draelos ZD, Green BA, Edison BL. An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. J Cosmet Dermatol. 2006;5(1):23-29. doi:10.1111/j.1473- 2165.2006.00219.x
14. Holmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol. 2013;69(6):1025-1032. doi:10.1016/j. jaad.2013.08.006
AUTHOR CORRESPONDENCE
Justin W. Marson MD justin.w.marson@gmail.com
